troglitazone has been researched along with Adenomatous Polyposis Coli, Familial in 3 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seed, B | 1 |
| Saez, E | 1 |
| Tontonoz, P | 1 |
| Nelson, MC | 1 |
| Alvarez, JG | 1 |
| Ming, UT | 1 |
| Baird, SM | 1 |
| Thomazy, VA | 1 |
| Evans, RM | 1 |
3 other studies available for troglitazone and Adenomatous Polyposis Coli, Familial
| Article | Year |
|---|---|
PPAR--the good news and the bad.
Topics: Adenomatous Polyposis Coli; Animals; Chromans; Humans; Hypoglycemic Agents; Mice; Receptors, Cytopla | 1998 |
PPARgamma and colorectal carcinoma: conflicts in a nuclear family.
Topics: Adenomatous Polyposis Coli; Animals; Chromans; Colorectal Neoplasms; Humans; Mice; Receptors, Cytopl | 1998 |
Activators of the nuclear receptor PPARgamma enhance colon polyp formation.
Topics: Adenocarcinoma; Adenomatous Polyposis Coli; Animals; Chromans; Diet; Humans; Ligands; Mice; Mice, In | 1998 |